NCT01371487View on ClinicalTrials.gov

GSK1120212 Food-effect Study

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 2, 2011

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions
Cancer
Interventions
DRUG

GSK1120212

Oral/once-daily single doses on Day 1 of Periods 1 and 2

Trial Locations (3)

37203

GSK Investigational Site, Nashville

48201

GSK Investigational Site, Detroit

78229

GSK Investigational Site, San Antonio

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01371487 - GSK1120212 Food-effect Study | Biotech Hunter | Biotech Hunter